Our findings underscore the critical importance of identifying SMARCA4 alterations across diverse tumor types, not only in thoracic neoplasms but also in gastrointestinal, gynecologic, and soft tissue malignancies. The gene discussed is SMARCA4; the disease is neoplasm.